Skin substitutes (cellular and tissue-based products, or CTPs) are FDA-cleared bioengineered or human-derived sheets — Apligraf, Oasis, GraftJacket, AmnioBand, EpiFix, and dozens of others — that are applied directly to chronic wounds to deliver growth factors, collagen, and an extracellular matrix scaffold. Under Medicare LCD L35041, these products are covered when a wound has failed at least 30 days of standard conservative care, the patient has adequate vascular supply, and underlying conditions are reasonably controlled. Healix360 supports the prior authorization, documentation, and Q-code billing workflow so the patient does not navigate it alone.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.